Ledger.Open graph →
SEC Form D · filed April 7, 2020

Pandion Therapeutics Holdco LLC

Offering
$80.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Christopher L. Fuglesang · Cambridge, MADirectorNancy L. Stagliano · Cambridge, MADirectorMitchell L. Mutz · Cambridge, MADirectorDaniel L. Becker · Cambridge, MADirectorAlan L. Crane · CAMBRIDGE, MADirectorVikas L. Goyal · Cambridge, MAExecJill L. Carroll · SAINT LOUIS, MODirectorJo L. Viney · Cambridge, MAExecCarlo L. Rizzuto · Cambridge, MADirectorDonald L. Frail · Cambridge, MADirectorRahul Kakkar · Cambridge, MAExec · DirectorChristopher L. Fuglesang · Cambridge, MADirectorCarlo L. Rizzuto · Cambridge, MADirectorNancy L. Stagliano · Cambridge, MADirectorDonald L. Frail · Cambridge, MADirectorMitchell L. Mutz · Cambridge, MADirectorRahul Kakkar · Cambridge, MAExec · DirectorDaniel L. Becker · Cambridge, MADirectorAlan L. Crane · Rochester, NYDirectorVikas L. Goyal · Cambridge, MAExecJill L. Carroll · SAINT LOUIS, MODirectorJo L. Viney · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗